Archana Hinduja

Final Results of the RHAPSODY Trial: A Multi‐Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A‐APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke

Patrick D. Lyden, Kent E. Pryor, Christopher S. Coffey et al. · Annals of Neurology · 2018 · 142 citations

Role of admission serum albumin levels in patients with intracerebral hemorrhage

Kaustubh Limaye, Ju Dong Yang, Archana Hinduja · Acta Neurologica Belgica · 2015 · 44 citations

Thrombosis, Medicine, Intracerebral Hemorrhage +9

Hematoma expansion in spontaneous intracerebral hemorrhage: predictors and outcome

Shadi Yaghi, Jamil Dibu, Eugene Achi et al. · International Journal of Neuroscience · 2014 · 43 citations

Predictors of poor outcome in patients with posterior reversible encephalopathy syndrome

Archana Hinduja, Kenneth Habetz, Sunil Kumar Raina et al. · International Journal of Neuroscience · 2016 · 42 citations

Perfusion Imaging Predicts Favorable Outcomes after Basilar Artery Thrombectomy

Carlo W. Cereda, Giovanni Bianco, Michael Mlynash et al. · Annals of Neurology · 2021 · 42 citations